期刊文献+

NEK2基因在口腔鳞状细胞癌中的表达及意义 被引量:9

The expression and significance of NEK2 mRNA in oral squamous cell carcinoma
下载PDF
导出
摘要 利用Real-Time PCR检测细胞周期相关蛋白激酶2(NEK2)mRNA在20例口腔正常黏膜组织及42例口腔鳞状细胞癌(OSCC)组织中的表达。结果显示,NEK2 mRNA在OSCC中高表达(P<0.050),不同分化程度(P<0.05)、不同临床分期组间差异具有统计学意义(P<0.05)。有无淋巴结转移(P>0.05)、不同年龄、不同性别组间差异无统计学意义(P>0.05)。NEK2基因表达增高可能参与OSCC的形成。 42 cases of OSCC and 20 of healthy tissues were studied to detect the expression of NIMA-related Kinase 2( NEK2) mRNA by Real-time PCR. Over expression of NEK2 mRNA was observed in OSCC( z =- 6. 328,P〈0. 05),the expression was correlated with the differentiation( z =- 5. 012,P〈0. 05) and clinical stage( z =- 4. 950,P〈0. 05) of the lesion,but not with the lymph node metastasis( z=- 0. 051,P〈0. 05),age( z =- 0. 365,P〉0. 05) and gender( z =- 3. 450,P〉0. 05). NEK2 gene may be involved in the development of OSCC.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2016年第3期436-438,共3页 Journal of Practical Stomatology
基金 贵州省国际合作计划(编号:黔科合外G字[2014]7009号)
关键词 细胞周期相关蛋白激酶2(Nek2) 口腔鳞状细胞癌 实时定量荧光聚合酶链反应 NIMA-related kinase 2(Nek2) Oral squamous cell carcinoma(OSCC) Real-time PCR
  • 相关文献

参考文献5

二级参考文献66

共引文献125

同被引文献51

  • 1Shin DS,Ribas A, The evolution of checkpoint blockade asa cancer therapy : What^ here,what^ next? [J] . Curr OpinImmunol, 2015,33:23 - 35.
  • 2Eggermont AM, Maio M,Robert C. Immune checkpoint in-hibitors in melanoma provide the cornerstones for curativetherapies[J]. Semin Oncol, 2015,42(3) :429 -435.
  • 3Topalian SL, Drake CG, Pardoll DM. Immune checkpointblockade : A common denominator approach to cancer thera-py[J]. Cancer Cell, 2015, 27(4) ;450-461.
  • 4Anderson AC. Tim-3 : An emerging target in the cancer im-munotherapy landscape[J]. Cancer Immunol Res, 2014,2(5):393 -398.
  • 5Ferris RL,Lu B,Kane LP. Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion [ J ] . J Immunol,2014,193(4) :1525 -1530.
  • 6SunH, SunC,Xiao W. Expression regulation of co- inhibi-tory molecules on human natural killer cells in response tocytokine stimulations[J]. Cytokine, 2014, 65( 1 ) :33 -41.
  • 7Campbell KS, Hasegawa J. Natural killer cell biology : Anupdate and future directions[J]. J Allergy Clin Immunol,2013,132(3):536-544.
  • 8Singh AK, Shukla NK, Das SN. Altered invariant naturalkiller T cell subsets and its functions in patients with oralsquamous cell carcinoma [ J ]. Scand J Immunol, 2013 , 78(5):468 -477.
  • 9Li H, Wu K, Tao K, et al. Tim-3/galectin-9 signalingpathway mediates T- cell dysfunction and predicts poor prog-nosis in patients with hepatitis B virus- associated hepatocel-lular carcinoma [ J ], Hepatology, 2012, 56 ( 4 ) : 1342 -1351.
  • 10Wang F, Hou H, Wu S, et al. Tim-3 pathway affects NKcell impairment in patients with active tuberculosis [ J ]. Cy-tokine, 2015,76(2) :270 -279.

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部